L1
|
L2
|
L3
|
L4
|
Supports
|
---|
CXCL10+ [23]
|
IFIT2+ [38]
|
ZNF710-
|
FECH+ [39]
|
95% (19/20)
|
| | |
BPGM+ [40]
|
95% (19/20)
|
| | |
SNCA+ [41]
|
95% (19/20)
|
| | |
SELENBP1+ [42]
|
95% (19/20)
|
| |
HBZ+
|
FECH+ [39]
|
95% (19/20)
|
| | |
BPGM+ [40]
|
95% (19/20)
|
| | |
SNCA+ [41]
|
95% (19/20)
|
| | |
SELENBP1+ [42]
|
100% (20/20)
|
| | |
TRIM46+
|
95% (19/20)
|
| |
SELENBP1+ [42]
|
HBZ+
|
95% (19/20)
|
| | |
SELENBP1+ [42]
|
95% (19/20)
|
| |
PPP4R4+
|
SELENBP1+ [42]
|
95% (19/20)
|
IFIT2+ [38]
|
IFIT2+ [38]
|
ZNF710-
|
FECH+ [39]
|
95% (19/20)
|
| | |
BPGM+ [40]
|
95% (19/20)
|
| | |
SNCA+ [41]
|
95% (19/20)
|
| | |
SELENBP1+ [42]
|
95% (19/20)
|
| |
HBZ+
|
FECH+ [39]
|
95% (19/20)
|
| | |
BPGM+ [40]
|
95% (19/20)
|
| | |
SNCA+ [41]
|
95% (19/20)
|
| | |
SELENBP1+ [42]
|
100% (20/20)
|
| | |
TRIM46+
|
95% (19/20)
|
| |
SELENBP1+ [42]
|
HBZ+
|
95% (19/20)
|
| | |
SELENBP1+ [42]
|
95% (19/20)
|
| |
PPP4R4+
|
SELENBP1+ [42]
|
95% (19/20)
|
TNFSF10+ [43]
|
IFIT2+ [38]
|
HBZ+
|
SELENBP1+ [42]
|
95% (19/20)
|
- []: hepatitis C-associated genes reported in previous literature; In: the nth item in a CTGR-SP; +: expressed genes; -: repressed genes.